Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Age and Genetics: Aging increases the risk of hemorrhoids due to the weakening of the tissues that support the veins in the rectum and anus
And thats something worth investing in
Quick-freeze, deep-etch visualization of the axonal cytoskeleton Trends Neurosci 1986
CpG and non-CpG methylation in epigenetic gene regulation and brain function
The News About the Semaglutide Pill In December 2025, the Food and Drug Administration approved the oral form of semaglutide, which, like the injection, mimics GLP-1 hormones to reduce appetite, slow digestion, improve blood sugar regulation and more
Home Medical news & Guidelines Anesthesiology Cardiology and CTVS Critical Care Dentistry Dermatology Diabetes and Endocrinology ENT Gastroenterology Medicine Nephrology Neurology Obstretics-Gynaecology Oncology Ophthalmology Orthopaedics Pediatrics-Neonatology Psychiatry Pulmonology Radiology Surgery Urology Laboratory Medicine Diet Nursing Paramedical Physiotherapy Health news Fact Check Bone Health Fact Check Brain Health Fact Check Cancer Related Fact Check Child Care Fact Check Dental and oral health fact check Diabetes and metabolic health fact check Diet and Nutrition Fact Check Eye and ENT Care Fact Check Fitness fact check Gut health fact check Heart health fact check Kidney health fact check Medical education fact check Men's health fact check Respiratory fact check Skin and hair care fact check Vaccine and Immunization fact check Women's health fact check AYUSH State News Andaman and Nicobar Islands Andhra Pradesh Arunachal Pradesh Assam Bihar Chandigarh Chattisgarh Dadra and Nagar Haveli Daman and Diu Delhi Goa Gujarat Haryana Himachal Pradesh Jammu & Kashmir Jharkhand Karnataka Kerala Ladakh Lakshadweep Madhya Pradesh Maharashtra Manipur Meghalaya Mizoram Nagaland Odisha Puducherry Punjab Rajasthan Sikkim Tamil Nadu Telangana Tripura Uttar Pradesh Uttrakhand West Bengal Medical Education Industry Tirzepatide proves to be more effective than semaglutide- Results of Surmount 5 Trial - Video Overview SURMOUNT-5 was a 72-week, Phase 3b, multicenter, randomized, open-label, comparator-controlled study that evaluated the efficacy and safety of tirzepatide 15 mg or MTD (10 mg or 15 mg) compared with semaglutide 2.4 mg or MTD (1.7 mg or 2.4 mg) in adults with obesity or overweight with at least one obesity-related complication, excluding diabetes
US$ 21.96
US$ 28.16
US$ 23.51
